Literature DB >> 28066326

No Association between Elevated Thyroid-Stimulating Hormone at Birth and Parent-Reported Problem Behavior at Preschool Age.

Caroline Trumpff1, Jean De Schepper2, Johan Vanderfaeillie3, Nathalie Vercruysse4, Jean Tafforeau5, Herman Van Oyen5, Stefanie Vandevijvere5.   

Abstract

OBJECTIVES: Mild level of iodine deficiency during pregnancy may reduce maternal thyroid hormone production and supply to the fetus hence affecting brain neurodevelopment. The aim of the present study was to investigate the association between elevated neonatal thyroid-stimulating hormone (TSH) level (>5 mU/L), used as a marker of maternal mild iodine deficiency during late pregnancy, and behavioral development of preschool children.
METHODS: This retrospective cohort study included 310 Belgian mothers and their children aged 4-5 years old with TSH levels in the range of 0.45-15 mU/L at birth. The TSH level was measured in dried blood spots on filter paper collected by heel stick 3-5 days after birth. Low birth weight, prematurely born children, or children with congenital hypothyroidism were excluded. The degree of behavioral problems was evaluated using the Child Behavior Check List (CBCL) for age 1½-5 years questionnaire. Relevant socioeconomic, maternal, and child factors were also collected.
RESULTS: TSH concentrations and CBCL scores were not associated both in univariate analysis and when adjusting for confounding factors in multivariate analysis. DISCUSSION: Elevated TSH concentrations measured at birth was not associated with behavioral development scores.

Entities:  

Keywords:  behavioral problems; iodine deficiency; pregnancy; preschool children; thyroid-stimulating hormone

Year:  2016        PMID: 28066326      PMCID: PMC5165276          DOI: 10.3389/fendo.2016.00161

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


Introduction

Iodine is essential for the synthesis of thyroid hormones that are involved in many functions including brain development (1, 2). While severe iodine deficiency is disappearing worldwide, mild iodine deficiency (MID) is still present in many developed countries (3). Pregnant women are at a higher risk of iodine deficiency because their nutritional iodine requirements are almost doubled due to physiological changes. Thyroid hormones are involved in several important steps of brain development including cell migration and differentiation (4). A sufficient transfer of maternal thyroid hormones to the fetal brain is necessary from the early stage of pregnancy, and a lack of thyroid hormones during pregnancy may disturb the brain development of the fetus. Even MID can lead to mild thyroid dysfunction that may affect the fetal brain development (5). Insufficient iodine stock can lead to maternal hypothyroxinemia that is a common condition in pregnancy characterized by a low level of free thyroxin with thyroid-stimulating hormone (TSH) within the normal range (6). Several studies have shown that maternal hypothyroxinemia can lead to impaired cognitive and psychomotor development in offspring (5, 7). Little is known about the impact of mild thyroid dysfunction during pregnancy on behavioral development of children. A prospective study conducted in an geographic area of moderate iodine deficiency in Italy found that children of hypothyroxemic mothers had an increased risk of developing attention deficit hyperactivity disorder (ADHD) symptomatology (8). However, that study was conducted on a very limited size sample. Two larger researches have been conducted in order to investigate the effect of maternal hypothyroxinemia on behavioral development of the offspring. One of these found a relationship between higher levels of maternal TSH and higher externalizing scores in children aged 1½ and 3 years old, while no association was found between maternal fT4 and total T4 and behavioral problem scores in children (9). In contrast, the second study found that maternal hypothyroxineamia was linked to an increased risk of showing ADHD symptoms at 8 years old (10). Another study found that MID during pregnancy, measured by urinary iodine excretion, was related in children of 4 years of age to impaired executive functioning (11), impairments that are known to be related to behavioral problems such as ADHD, oppositional defiant disorder, or conduct disorder (11). Put together, these data indicate a potential implication of maternal and/or fetal thyroid dysfunction in the vulnerability of children to behavioral problems. However, the number of studies is limited and their results are controversial, thereby requiring further studies. Thyroid-stimulating hormone concentration in whole blood measured at birth has been proposed as an indicator of maternal iodine status during late pregnancy (12–14). When thyroid disease is excluded, the thyroid hormone level is mainly dependent on body iodine stocks provided by nutrition. TSH is liberated in the bloodstream to stimulate the production of thyroid hormones when they are lacking. When their amount is adapted, TSH secretion is stopped by a negative feedback loop. In cases of iodine deficiency, iodine stocks are insufficient to produce thyroid hormones, and the TSH concentration increases in the bloodstream. Following this logic, an increased concentration can be used as an indicator of iodine deficiency. The world health organization (WHO) has proposed to use the TSH results provided by screening programs for congenital hypothyroidism as an index for the evaluation of iodine status of the population (12). A proportion of TSH results with a concentration above 5 mU/L below 3% was proposed as an indicator of iodine sufficiency, between 3 and 19.9% of MID, between 20 and 39.9% of moderate iodine deficiency and above 40% of severe iodine deficiency (12). Several studies showed that elevated TSH levels after birth were associated with suboptimal cognitive and psychomotor outcomes (15–19). However, some factors other than iodine deficiency can increase TSH concentration at birth such as timing of testing, mothers or newborn health condition, and drug intake (20, 21). We previously reported no association between elevated TSH measured at birth and cognitive and psychomotor development of preschool children when confounding factors were taken into account (22, 23). To our knowledge, the association between elevated neonatal TSH and behavioral problems has never been investigated. The aim of this study was to investigate the association between elevated TSH concentration at birth, used as a marker of MID during late pregnancy, and behavioral development of preschool-age children, taking into account potential confounding factors. We hypothesized that a higher TSH level in newborn children would be related to the childrens’ increased tendency to internalize and externalize problems, assessed using the age-adapted Child Behavior Check List questionnaire.

Materials and Methods

Subjects

We used data from the PsychoTSH study, a Belgian retrospective cohort study that has been previously described in detail (22–24). In total, 310 children aged 4–5 years old with a neonatal TSH concentration in the range 0.45–15 mU/L were included in the present study. Neonatal TSH data were provided by the Brussels newborn screening center for metabolic disorders [Laboratoire de Pédiatrie, Université Libre de Bruxelles (ULB), Brussels]. The selection of children was performed from the total samples of, respectively, 29,013, 29,602, and 30,126 neonates, screened in 2008, 2009, and 2010. Children were stratified by sex and TSH level: for each sex and TSH interval, 19 children were selected randomly (0–1, 1–2, 2–3, 3–4, 4–5, 5–6, 6–7, 7–8, 8–9, and 9–15 mU/L). The day of collection was taken into account for the selection, only children with sample collected 3–5 days after birth were included. Exclusion criteria were (1) congenital hypothyroidism (15 mU/L or higher), (2) prematurity (<37 weeks), and (3) low birth weight (<2,500 g). Children with neurological disease and/or born from multiple birth were excluded during the recruitment procedure. The sample size of the TSH study was calculated for the relationship between TSH and cognitive score (22, 24).

Ethics and Privacy Commission

Before the start of the procedure, a written informed consent was obtained from the parents of the children. The Ethical Committee of the Erasmus Hospital (Université Libre de Bruxelles, Brussels, Reference CCB: B40620109191) in accordance with the Code of Ethics of the World Medical Association for experiments involving humans (Declaration of Helsinki) gave the ethical approval of the study. The study was also approved by the Belgian Privacy Commission (Reference: RN 29/2012).

TSH Measurements

Neonatal TSH level was measured in dried blood spots on filter paper collected by a heel stick 3–5 days after birth using a time-resolved fluoroimmunoassay (Autodelfia method) (25). The reproducibility of the TSH values was tested in the range 0–15 mU/L. In order to determine the coefficient of variation, TSH was analyzed twice at 50 different TSH values. For the TSH values ranging from 0.9 to 15 mU/L, the coefficient of variation was below 20%. For the TSH values below 0.9 mU/L, a TSH value of 0.45 mU/L was used in the statistical analysis.

Urinary Iodine Concentration (UIC) Assessment

A sample of urine was collected from the child during the home visit (at 4–5 years) to determine the current iodine status among the children included in the study. The urine samples were frozen at −80°C until analysis. Urinary iodine concentration (UIC) was measured using a modification of the Sandell–Kolthoff reaction with spectrophotometric detection (26) at the Erasmus Hospital.

Anthropometric Measurements Methodology

During the procedure, body weight, height, and child head circumference were measured using SECA 815 and SECA 804 scales, a SECA 214 stadiometer and a flexible tape measure SECA 212.

Psychosocial Assessment

Psychosocial development, including behavioral and emotional problems, was assessed using the French version of the “Child Behavior Check List (CBCL) for ages 1½–5 years.” This standardized questionnaire was developed by Achenbach assessing social competence, behavioral, and emotional problems in children aged 1½–5 years old (27). The CBCL/1½–5 has a good reliability and validity (27). The syndrome scales has been shown to have an acceptable to good fit in 23 studies across diverse societies (28). The internal consistency of internalizing and externalizing syndrome scales has been tested previously and Cronbach’s alpha vary between 0.88 and 0.92 (29). The Child Behavior Checklist has been used previously in preschool children to assess the effect of maternal thyroid dysfunction on behavioral problem (7, 9) or the effect of subclinical hypothyroidism on psychosocial development (30). The CBCL questionnaire was filled out by mothers during a home visit. It enables the rating of problematic behaviors based on a description of the child’s functioning for the last two months. The CBCL enables the calculation of 3 scores: a total problem score, a score on internalizing problems, and a score on externalizing problems. The internalizing problems score is calculated from the following four syndrome scales: emotional reactive, anxious depressed, somatic complaints, and withdrawal. The externalizing problems score is calculated from the following two syndrome scales: attention problems and aggressive behavior. The total problems score includes internalizing and externalizing scores together with the “sleep problems” syndrome scale. In addition to those three scores, the CBCL checklist enables the calculation of the following DSM-oriented scores: affective problems, anxiety problems, pervasive developmental problems, attention deficit/hyperactivity problems, and oppositional defiant problems. The Achenbach’s manual provides functioning cut-off points in order to differentiate between a “normal” and a “problematic” score. These cut-off points provide a normal (below 65), a borderline (between 65 and 70), and a clinical range (higher than 70) for the scores. The ASEBA Windows software Assessment Data Manager (ADM) was used to compute the scores.

Descriptive Variables, Covariates, and Effects Modifiers

Information about covariates and effect modifiers was retrieved from the data provided by the ULB newborn screening center for metabolic disorders, the child’s health booklet, and a self-report questionnaire filled out by the mother during the home visit. The following information was collected about the pregnancy history and the maternal antecedents: maternal thyroid disease, drug intake, alcohol consumption and cigarette smoking before or during pregnancy, gestational diabetes and treatment of diabetes, maternal age at birth, reproductive history, parity, gravidity, pre-pregnancy body mass index (BMI), and maternal weight gain during pregnancy. The following information was collected about the delivery: type of delivery and season of birth. The following child parameters were retrieved: perinatal anoxia, health problems of the newborn, breastfeeding, chronic disease of the child, nursery school attendance, child bilingualism, and previous cognitive assessment of the child. The socioeconomic background data collected were as follows: maternal/paternal education and employment, household income, marital status, area of residence, maternal age, housing. In addition, several questions contained in the self-reported questionnaire aimed to assess different psychological factors potentially influencing the mental development of the child: child negative life events, maternal mental health, maternal social support, marital discord and parent–child interactions. Maternal mental health was also assessed using the “General Health Questionnaire” items and vitality scale questionnaire of the “Short Form Health Survey” (31).

Data Analysis

Statistical analysis was performed using SAS statistical software 9.3 (SAS Institute Inc., Cary, NC, USA) for univariate analysis and Stata version 13 (StataCorp, College Station, TX, USA) for multivariate analysis. Statistical tests were two-sided and tests with p-value < 0.05 were considered statistically significant. Neonatal TSH values and UIC were presented as median, and IQR and CBCL scores were presented as mean and SD. Neonatal TSH values were classified in two groups: below 5 mU/L and higher or equal to 5 mU/L. Univariate associations between CBCL scores and TSH were assessed using Pearson correlation. Univariate association between CBCL scores and maternal and children parameters was assessed using linear regression for continuous variables and with student’s t-test and ANOVA with Bonferroni correction for categorical variables. In addition, Chi square test was performed to analyze multivariate association between TSH levels (<5 mUI/L and ≥5 mUI/L) and borderline (65< and <70)/clinical score (≥70) at CBCL checklist. Multivariate linear models were used to study the predictors of variation of CBCL scores in children. All variables associated with CBCL scores with a test p < 0.20 were included in the selection procedure. TSH was dichotomized using a cut-off of 5 mU/L. A stepwise backward selection procedure with a probability of entry of 0.10 and exit probability of 0.15 was used to build the final multiple linear regression models. The normality of the distribution of residuals was tested using normal plot of residuals. Linearity and homoscedasticity of residuals were checked by examination of the plot of standardized residual. Collinearity between predictors was tested using the test of variance inflation factor (VIF), and individuals’ VIF for each parameter in the model was around 1. Univariate association between the variables to be inserted in the model was tested with Pearson correlation. Variables correlated with each other were not included together in the model.

Results

Demographic Characteristics

Descriptive characteristics by gender of the population studied are shown in Table 1. In total, 310 children (n = 137 girls) aged 4 and 5 years were included in the study.
Table 1

Descriptive and demographic characteristics of the study population according to gender.

TotalMaleFemale

N%N%N%
Thyroid-stimulating hormone level at birth (mU/L)
0.45–14715.2268.4216.8
23511.3216.8144.5
34113.2237.4185.8
44012.9206.5206.5
53411.0196.1154.8
63912.6206.5196.1
73511.3216.8144.5
8144.5103.241.3
9144.561.982.6
10–15113.672.341.3
Age at examination
4 years23475.513042.010433.5
5 years7624.54313.93310.6
Children ethnicity
Europe (Caucasian)24884.613947.410937.2
Asia31.020.710.3
Sub-Saharan Africa155.172.482.7
North Africa279.2165.5113.8

PsychoTSH study (.

N, number of subjects.

Descriptive and demographic characteristics of the study population according to gender. PsychoTSH study (. N, number of subjects.

Neonatal TSH Levels at Birth and Current Iodine Status of the Studied Population

The median (range) TSH level at birth of the study sample was 3.6 mU/L [1.8–5.8 (IQR), 0.45–13.9 (min–max)]. In this sample, 197 (63.5%) children had a TSH level measured at birth lower than 5 mUI/L, and 113 (36.5%) children had a TSH higher or equal to 5 mUI/L. The median iodine concentration of the sample was 141.4 µg/L [87.9–239.9 (IQR)] indicating iodine sufficiency of the children sample.

Univariate Association between CBCL Scores and Studied Parameters

The mean CBCL total problem score was 48.0 [10.1 (SD), 28–88 (min–max)]; the mean CBCL external problem score was 46.7 [9.5 (SD), 28–77 (min–max)]; and the mean CBCL internal problem was 49.5 [11.1 (SD), 29–86 (min–max)]. Several child, maternal, socioeconomic, and iodine status parameters were shown to be associated with CBCL scores in univariate analysis (see Tables 2–4). A negative association was found between neonatal TSH concentration, CBCL total problem score (p = 0.038) and internalizing problem score (0.023). No significant associations were found between DSM-oriented scores and neonatal TSH levels (data not shown).
Table 2

Association of CBCL scores at preschool age with infant, maternal, and household characteristics: categorical variables.

Total
Total problem score
Externalizing score
Internalizing score
N%MeanSDp-ValueaMeanSDp-ValueaMeanSDp-Valuea
Children characteristics
Gender0.0820.0040.381
 Male17355.8148.8710.3148.0510.0750.0510.86
 Female13744.1946.869.7444.968.5048.9411.31
Neonatal hospital attendance0.0280.1170.047
 Yes248.0052.0412.9349.3310.5253.5812.93
 No27692.0047.369.6846.199.2848.9210.80
Breastfeeding at 6 months0.1210.0340.165
 <6 months15048.5447.079.8345.739.08*48.6411.11
 >6 months12339.8148.069.4646.559.0949.7110.59
 no breastfeeding3611.6550.9212.8250.3111.68*52.5312.39
Negative life event0.0130.0560.019
 Less than 326786.4147.389.7646.229.2748.9710.92
 More than 34213.5951.5511.4949.2410.5653.2911.46
Socioeconomics characteristics
Monthly income0.0010.0540.006
 <2,000 euro3812.6752.7011.9249.2210.2154.1411.97
 ≥2,000 euro26287.3347.069.7146.029.3148.7110.92
Mother education level<0.0001*0.001*<0.0001*
 No/primary103.2852.2011.3251.6010.7553.909.85
 Lower high school227.2156.9010.5051.769.2058.6210.53
 Upper high school5016.3951.148.7549.207.1752.599.99
 University or higher22373.1146.109.7445.299.6747.7910.96
Maternal characteristics
Delivery0.0970.2250.172
 Normal23475.7347.1910.0646.119.4748.7311.13
 Cesarean4313.9249.168.9146.958.7651.869.93
 With vacuum3110.0351.6511.5749.6510.2352.1612.01
 With forcepts10.3243.0040.0045.00
Parity—First child0.0060.1580.002
 Yes13242.7249.779.4847.529.0051.7810.29
 No17757.2846.5510.3845.989.7847.7811.39
Previous miscarriage0.0120.0260.150
 Yes7624.6850.3511.7648.6510.1851.0112.78
 No23275.3247.009.3745.849.1548.8910.43
Smoking during pregnancy0.0000.0010.001
 ≥ 10 cigarettes/day61.9462.8314.1659.0012.4164.3311.04
 <10 cigarettes/day or non-smoking30498.0647.699.8146.449.3249.2710.87
Alcohol during pregnancy0.3560.7860.168
 Non-consumer20968.0848.269.9846.699.1450.0810.91
 Still consuming9831.9247.1110.4246.3810.2348.2011.45
Mother social support0.0190.0980.133
 3 or less9831.7249.9110.7847.949.2050.9211.71
 4 or more21168.2846.989.7046.009.6348.8710.78
Mother mental distress score<0.00010.031<0.0001
 Low (<4)25988.1047.169.8346.179.3648.8610.87
 Elevated (>4)3511.9053.6911.6249.8910.6755.8911.31
Mother vitality Index0.0850.0230.570
 Optimal vitality26989.0748.2510.1847.159.4549.5011.32
 Suboptimal vitality3310.9344.979.9243.099.4648.3110.15

PsychoTSH study (.

A higher CBCL score is related to higher developmental problems.

.

*Significant with Bonferroni correction for multiple testing.

N, number of subject.

Statistically significant p-Values (p < 0.05) are highlighted in bold.

Table 4

CBCL scores at preschool age and markers of iodine status.

Total problem score
Externalizing score
Internalizing score
N%MeanSDp-ValueaMeanSDp-ValueaMeanSDp-Valuea
Pregnancy and neonatal period
Neonatal TSH level (mU/L)0.1520.0510.266
 <519763.5548.6010.3047.499.6650.0911.19
 ≥511336.4546.899.6845.299.1648.6410.81
Vitamins during pregnancy0.1910.2860.139
 Containing iodine5143.5947.439.2946.028.6748.7310.76
 No vitamins6656.4149.8910.4147.9810.5151.7310.63
Children characteristics
Urinary iodine concentration (μg/L)0.0860.1160.098
 <1008230.3748.379.9047.189.2049.9010.93
 100–1496724.8149.1210.6947.989.7950.6511.96
 150–2946022.2246.369.2844.599.2749.2710.27
 ≥2506122.5945.119.4244.929.5746.1110.08
Household salt0.1890.0920.356
 Iodinised salt9634.5347.399.7746.429.6348.8210.91
 Non-iodinised salt17061.1547.6310.1145.999.3149.4011.05
 No salt124.3253.0013.6452.2511.8953.7514.72
Child dietary supplement intake0.0040.0040.025
 Yes19665.5546.719.5445.549.1248.4710.71
 No10334.4550.2610.6048.849.8751.5011.47

PsychoTSH study (.

A higher CBCL score is related to higher developmental problems.

.

*Significant with Bonferroni correction for multiple testing.

N, number of subject.

Statistically significant p-Values (p < 0.05) are highlighted in bold.

Association of CBCL scores at preschool age with infant, maternal, and household characteristics: categorical variables. PsychoTSH study (. A higher CBCL score is related to higher developmental problems. . *Significant with Bonferroni correction for multiple testing. N, number of subject. Statistically significant p-Values (p < 0.05) are highlighted in bold. Association of CBCL scores at preschool age with infant, maternal, and household characteristics: continuous variables. PsychoTSH study (. A higher CBCL score is related to higher developmental problems. . . IQR, inter quartile range; HC, head circumference; N, number of subject. Statistically significant p-Values (p < 0.05) are highlighted in bold. CBCL scores at preschool age and markers of iodine status. PsychoTSH study (. A higher CBCL score is related to higher developmental problems. . *Significant with Bonferroni correction for multiple testing. N, number of subject. Statistically significant p-Values (p < 0.05) are highlighted in bold.

Neontal TSH Concentration and Severity Rating at CBCL Scores

Child Behavior Check List scores in the borderline and clinical range were not more frequently found in the children with elevated TSH compared to those with TSH < 5 mU/L as shown in Figure 1.
Figure 1

Neonatal TSH concentration and severity rating at CBCL scores. PsychoTSH study (N = 310), Belgium, 2008–2014. Clinical T-scores <65, borderline <65 and <70, and clinical >70. Chi-squared test of independence was non-significant. ODP, oppositional defiant problems; ADHD, attention-deficit hyperactivity disorder; TSH (mUI/L), thyroid-stimulating hormones.

Neonatal TSH concentration and severity rating at CBCL scores. PsychoTSH study (N = 310), Belgium, 2008–2014. Clinical T-scores <65, borderline <65 and <70, and clinical >70. Chi-squared test of independence was non-significant. ODP, oppositional defiant problems; ADHD, attention-deficit hyperactivity disorder; TSH (mUI/L), thyroid-stimulating hormones.

Predictors of CBCL Scores Assessed by Multiple Linear Regression Analysis

The multiple linear regressions of factors explaining variation of CBCL scores at preschool age are shown in Table 5. Elevated TSH concentration at birth was not associated with any CBCL scores. The predictors of higher CBCL scores (meaning higher problems score) were male gender (total problem score, p = 0.008; externalizing score, p = 0.001), no dietary supplement intake by the child (total problem score, p = 0.003; externalizing score, p = 0.006), neonatal hospital attendance (total problem score, p = 0.023; internalizing score p = 0.093), child negative life event occurrence (total problem, score, p = 0.008), maternal education level lower than university (total problem score, p < 0.0001; externalizing score, p < 0.0001; internalizing score p < 0.0001), mother’s lifetime smoking behavior up to child birth (internalizing score, p = 0.031), maternal suboptimal vitality (externalizing score, p = 0.009), and higher maternal mental distress (total problem score, p < 0.0001).
Table 5

Multiple linear regression of factors explaining variation of CBCL scores at preschool age.

Total problem score (N = 269)
Externalizing score (N = 282)
Internalizing score (N = 289)
R2 = 22%
R2 = 14%
R2 = 13%
b (SE)p-Valueb (SE)p-Valueb (SE)p-Value
TSH (mU/L)0.1680.1260.104
 <5RefRefRef
 ≥5−1.57 (1.14)−1.71 (1.11)−2.12 (1.29)
Gender0.0080.001
 FemaleRefRef
 Male3.05 (1.15)3.52 (1.08)
Mother education levelp < 0.0001p < 0.0001p < 0.0001
 University or higherRefRefRef
 <University or higher6.04 (1.28)4.68 (1.24)6.42 (1.43)
Child dietary supplement intake0.0030.006
 YesRefRef
 No3.53 (1.19)3.18 (1.15)
Mother Vitality Index0.009
 Suboptimal vitalityRef
 Optimal vitality−4.69 (1.77)
Maternal mental distress scorep < 0.0001
 Low (<4)Ref
 Elevated (>4)6.54 (1.28)
Smoking during lifetime0.031
 NoRef
 Yes2.89 (1.33)
Neonatal hospital attendance0.0230.093
 YesRefRef
 No−4.79 (2.09)−3.83 (2.27)
Child negative life events0.008
 <2Ref
 ≥23.22 (1.20)

PsychoTSH study (.

A higher CBCL score is related to higher developmental problems.

.

N, number of subject; Ref, referent.

Multiple linear regression of factors explaining variation of CBCL scores at preschool age. PsychoTSH study (. A higher CBCL score is related to higher developmental problems. . N, number of subject; Ref, referent.

Discussion

Our study was the first to investigate the association between the elevation of neonatal TSH level at birth, used as a marker for iodine deficiency during late pregnancy, and the subsequent behavioral development of the offspring. Children with a neonatal TSH above 5 mU/L—used as a marker of iodine deficiency during late pregnancy—were found to have similar internalizing and externalizing behavioral problems scores to children with lower neonatal TSH levels, after adjusting for children and maternal covariates. Major factors associated with higher CBCL scores (indicative of higher problems) in multivariate analysis in preschool children were: male gender, neonatal hospital attendance, no dietary supplement intake by the child, negative life child events, lower maternal education level, maternal lifetime smoking behavior up to child birth, maternal psychological distress, and maternal low vitality. Previous research has shown that maternal MID and/or mild thyroid dysfunction could lead to behavioral problems in offspring later in life. A prospective study conducted in Sicily, Italy, investigated neuropsychological profiles of 16 children aged 8–10 years old living in a area with moderate iodine deficiency and 11 children in a control group living in an iodine-sufficient area in regards to the thyroid function of their mother during pregnancy (8). They found that 68% of the children showed ADHD symptoms in the iodine deficient area compared to no children in the iodine-sufficient area. In the iodine deficient area, 87.5% of the children born from hypothyroxinemic mothers had ADHD (8). A study conducted on the Dutch Generation R cohort found that maternal hypothyroxineamia during pregnancy was linked to an increased risk of showing ADHD symptoms at 8 years of age (10). Another study conducted on the Generation R cohort study found that MID during pregnancy, measured by urinary iodine excretion, was related with impaired executive functioning in children of 4 years old (11). Executive functioning involves inhibition, working memory, and organization skills. Impairments in cognitive functioning have been linked to behavioral problems such as ADHD, oppositional defiant disorder, or conduct disorder (11). In line with the findings of our study, several other studies did not find any relationship between mild thyroid dysfunction potentially due to MID (maternal low fT4) and behavioral problems in the offspring. A study on the Generation R study cohort found no association between maternal fT4 measured before 18th weeks of pregnancy and total T4 and CBCL behavioral problems scores in children at 1½ and 3 years old (9). On the other hand, they found a relationship between higher levels of maternal TSH and higher externalizing scores in children at 1½ and 3 years old. A study carried out in Finland on 9,479 children aged 8 years old in order to look for an association between maternal thyroid dysfunction and ADHD in the offspring found similar results. No association between maternal low fT4 during pregnancy and ADHD in the offspring was found (32). However, girls whose mother had elevated TSH levels during pregnancy had a higher risk of ADHD (32). In contrast to those findings, a Danish epidemiological study (N = 30,295) found no relationship between maternal hypothyroidism and ADHD symptoms in the offspring (33). A higher risk of ADHD in children whose mothers were diagnosed with hyperthyroidism after childbirth (vs. the one diagnosed prior to childbirth) was observed (33). In the Netherlands, the Generation R study cohort (N = 3,139) investigated the association between thyroid peroxidase antibodies (TPOAbs) in healthy pregnant women and child behavior, using the Child Behavior Checklist. A higher risk of behavioral problems and ADHD was found in children whose mothers had elevated TPOAbs during pregnancy (7). Studies such as ours, which investigate the impact of neonatal TSH levels as an indicator of MID during pregnancy (16–18, 34), only indicate the iodine status during late pregnancy. Subclinical impairment of cognitive and psychomotor development secondary to maternal hypothyroxineamia were found in studies investigating the first half of pregnancy (35–38). In several studies, no adverse outcomes were observed when hypothyroxineamia was studied from midpregnancy (39, 40). However, some studies did not find neurodevelopmental problems in children of mothers with hypothyroxinemia (41) or low urinary iodine excretion measured in the first trimester of pregnancy (42). The present study was conducted on a large sample stratified by gender and TSH ensuring that the whole range of TSH values below the clinical threshold for the diagnosis of congenital hypothyroidism was included. According to WHO, a proportion of neonates with a concentration of TSH above 5 mUI/L between 3 and 19% indicates MID (12). In Belgium, the frequency of neonatal TSH concentrations above 5 mUI/L fluctuated between 2.6 and 3.3% from 2009 to 2011 (43). This proportion was very low in comparison to results found for Belgian women of childbearing age. Indeed a study has shown that they had a median UIC indicative of MID in the year 2010–2011 (44). However, a median UIC indicative of iodine sufficiency was found in school-aged children (45). Many factors other than iodine deficiency can influence TSH measured at birth such as the timing of the blood sampling, the use of iodine-containing antiseptics around birth, or exposure to some organochlorines called endocrine disruptors (20, 21). The effect of MID during pregnancy on children behavioral development should thus be complemented by prospective studies using other markers of iodine deficiency during from first trimester of pregnancy, such as maternal UIC or maternal hypothyroxinemia. Despite the fact that a whole range of variables were collected and taken into account to avoid a confounding effect, it is possible that there is a remaining confounding effect. Other study limitations include its retrospective design, self-reported data, and the fact that behavioral problems were assessed at preschool age rather than at school age (when hyperactive and impulsive symptoms are the more important) and using a self-reported questionnaire rather than a direct psychological assessment by a psychologist. Future studies aiming to assess MID during pregnancy on child behavioral development should investigate a larger sample, be prospective, and use other markers of iodine deficiency from the first trimester of pregnancy, such as maternal UIC or maternal hypothyroxinemia. Ideally, the behavioral development should be assessed both at preschool and school age.

Conclusion

The present study was the first to investigate the association between behavioral development of preschoolers using neonatal TSH concentration as a surrogate marker of maternal MID during late pregnancy. No associations were found between neonatal TSH level and children’s behavioral development.

Ethics Statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Author Contributions

All authors contributed to the conception and the design of the study, the data interpretation, and the revision of the article. CT wrote the manuscript, performed the data collection and the data analysis. All the authors approved the final version of the article.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Table 3

Association of CBCL scores at preschool age with infant, maternal, and household characteristics: continuous variables.

Total problem scoreExternalizing scoreInternalizing score

Pearson correlation

NMedianIQRRp-ValueaRp-ValueaRp-Valuea
TSH (mUI/L)3103.61.8–5.9−0.120.038−0.100.081−0.130.023

Univariate linear regression

NMeanSDbSEPbbSEPbbSEPb
Term pregnancy (week)30839.31.6−0.260.360.481−0.250.340.473−0.370.400.360
Birth weight (g)3103,394.2429.80.000.000.9680.000.000.6600.000.000.314
Birth length (cm)31050.03.2−0.140.180.444−0.040.170.806−0.270.200.187
Birth HC (cm)26934.63.10.210.190.2670.180.180.3340.180.210.389
Mother age (years)31036.55.1−0.180.110.117−0.070.110.498−0.260.120.040

PsychoTSH study (.

A higher CBCL score is related to higher developmental problems.

.

.

IQR, inter quartile range; HC, head circumference; N, number of subject.

Statistically significant p-Values (p < 0.05) are highlighted in bold.

  40 in total

1.  Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study.

Authors:  Jens Henrichs; Jacoba J Bongers-Schokking; Jacqueline J Schenk; Akhgar Ghassabian; Henk G Schmidt; Theo J Visser; Herbert Hooijkaas; Sabine M P F de Muinck Keizer-Schrama; Albert Hofman; Vincent V W Jaddoe; Willy Visser; Eric A P Steegers; Frank C Verhulst; Yolanda B de Rijke; Henning Tiemeier
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

2.  Preschool psychopathology reported by parents in 23 societies: testing the seven-syndrome model of the child behavior checklist for ages 1.5-5.

Authors:  Masha Y Ivanova; Thomas M Achenbach; Leslie A Rescorla; Valerie S Harder; Rebecca P Ang; Niels Bilenberg; Gudrun Bjarnadottir; Christiane Capron; Sarah S W De Pauw; Pedro Dias; Anca Dobrean; Manfred Doepfner; Michele Duyme; Valsamma Eapen; Nese Erol; Elaheh Mohammad Esmaeili; Lourdes Ezpeleta; Alessandra Frigerio; Miguel M Gonçalves; Halldor S Gudmundsson; Suh-Fang Jeng; Pranvera Jetishi; Roma Jusiene; Young-Ah Kim; Solvejg Kristensen; Felipe Lecannelier; Patrick W L Leung; Jianghong Liu; Rosario Montirosso; Kyung Ja Oh; Julia Plueck; Rolando Pomalima; Mimoza Shahini; Jaime R Silva; Zynep Simsek; Andre Sourander; Jose Valverde; Karla G Van Leeuwen; Bernardine S C Woo; Yen-Tzu Wu; Stephen R Zubrick; Frank C Verhulst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11-11       Impact factor: 8.829

3.  Neonatal thyroid-stimulating hormone level is influenced by neonatal, maternal, and pregnancy factors.

Authors:  Caroline Trumpff; Stefanie Vandevijvere; Rodrigo Moreno-Reyes; Jean Vanderpas; Jean Tafforeau; Herman Van Oyen; Jean De Schepper
Journal:  Nutr Res       Date:  2015-09-02       Impact factor: 3.315

4.  Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism.

Authors:  Manuela Cerbone; Carmela Bravaccio; Donatella Capalbo; Miriam Polizzi; Malgorazata Wasniewska; Daniela Cioffi; Nicola Improda; Mariella Valenzise; Dario Bruzzese; Filippo De Luca; Mariacarolina Salerno
Journal:  Eur J Endocrinol       Date:  2011-02-03       Impact factor: 6.664

5.  Maternal thyroid function during pregnancy and behavioral problems in the offspring: the generation R study.

Authors:  Akhgar Ghassabian; Jacoba J Bongers-Schokking; Jens Henrichs; Vincent W V Jaddoe; Theo J Visser; Willy Visser; Sabine M P F de Muinck Keizer-Schrama; Herbert Hooijkaas; Eric A P Steegers; Albert Hofman; Frank C Verhulst; Jan van der Ende; Yolanda B de Rijke; Henning Tiemeier
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

6.  Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5.5 years.

Authors:  Fiona L R Williams; Jennifer Watson; Simon A Ogston; Theo J Visser; Robert Hume; Peter Willatts
Journal:  J Clin Endocrinol Metab       Date:  2013-01-15       Impact factor: 5.958

7.  A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration.

Authors:  Eva Ausó; Rosalía Lavado-Autric; Estela Cuevas; Francisco Escobar Del Rey; Gabriella Morreale De Escobar; Pere Berbel
Journal:  Endocrinology       Date:  2004-04-15       Impact factor: 4.736

8.  Association between borderline neonatal thyroid-stimulating hormone concentrations and educational and developmental outcomes: a population-based record-linkage study.

Authors:  Samantha J Lain; Jason P Bentley; Veronica Wiley; Christine L Roberts; Michelle Jack; Bridget Wilcken; Natasha Nassar
Journal:  Lancet Diabetes Endocrinol       Date:  2016-07-22       Impact factor: 32.069

9.  Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine.

Authors:  S Pino; S L Fang; L E Braverman
Journal:  Clin Chem       Date:  1996-02       Impact factor: 8.327

10.  Neonatal thyroid-stimulating hormone concentration and psychomotor development at preschool age.

Authors:  Caroline Trumpff; Jean De Schepper; Johan Vanderfaeillie; Nathalie Vercruysse; Herman Van Oyen; Rodrigo Moreno-Reyes; Jean Tafforeau; Stefanie Vandevijvere
Journal:  Arch Dis Child       Date:  2016-07-08       Impact factor: 3.791

View more
  4 in total

Review 1.  Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?

Authors:  Samantha Lain; Caroline Trumpff; Scott D Grosse; Antonella Olivieri; Guy Van Vliet
Journal:  Eur J Endocrinol       Date:  2017-07-10       Impact factor: 6.664

2.  Maternal Thyroid Function During Pregnancy or Neonatal Thyroid Function and Attention Deficit Hyperactivity Disorder: A Systematic Review.

Authors:  Samantha S M Drover; Gro D Villanger; Heidi Aase; Thea S Skogheim; Matthew P Longnecker; R Thomas Zoeller; Ted Reichborn-Kjennerud; Gun P Knudsen; Pål Zeiner; Stephanie M Engel
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822

3.  Cord Blood Thyroid Hormones and Neurodevelopment in 2-Year-Old Boys and Girls.

Authors:  Pianpian Fan; Yuanzhi Chen; Zhong-Cheng Luo; Lixiao Shen; Weiye Wang; Zhiwei Liu; Jun Zhang; Fengxiu Ouyang
Journal:  Front Nutr       Date:  2021-12-20

Review 4.  Congenital hypothyroidism: insights into pathogenesis and treatment.

Authors:  Christine E Cherella; Ari J Wassner
Journal:  Int J Pediatr Endocrinol       Date:  2017-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.